These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 17181429

  • 21. [Practical advice for a safe, effective and well tolerated therapy of multiple sclerosis].
    Buttmann M, Rieckmann P.
    MMW Fortschr Med; 2006 May 15; Spec no. 2():49-50, 52-3. PubMed ID: 20104715
    [Abstract] [Full Text] [Related]

  • 22. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation.
    Qasqas SA, McPherson C, Frishman WH, Elkayam U.
    Cardiol Rev; 2004 May 15; 12(4):201-21. PubMed ID: 15191632
    [Abstract] [Full Text] [Related]

  • 23. Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective.
    Tremlett HL, Oger J.
    Mult Scler; 2008 Jan 15; 14(1):94-105. PubMed ID: 17881392
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of pediatric multiple sclerosis and variants.
    Pohl D, Waubant E, Banwell B, Chabas D, Chitnis T, Weinstock-Guttman B, Tenembaum S, International Pediatric MS Study Group.
    Neurology; 2007 Apr 17; 68(16 Suppl 2):S54-65. PubMed ID: 17438239
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pregnancy and multiple sclerosis.
    Houtchens MK.
    Semin Neurol; 2007 Nov 17; 27(5):434-41. PubMed ID: 17940922
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. New options for early treatment of multiple sclerosis.
    Tintoré M.
    J Neurol Sci; 2009 Feb 01; 277 Suppl 1():S9-S11. PubMed ID: 19200870
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Interferon-beta for multiple sclerosis: Long-term benefits?
    Rudick RA, Cutter G.
    Ann Neurol; 2007 Apr 01; 61(4):283-5. PubMed ID: 17444503
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis.
    Girouard N, Théorêt G.
    Can J Neurosci Nurs; 2008 Apr 01; 30(4):18-25. PubMed ID: 19146204
    [Abstract] [Full Text] [Related]

  • 36. Family planning, pregnancy and breastfeeding in multiple sclerosis.
    Holmøy T, Torkildsen Ø.
    Tidsskr Nor Laegeforen; 2016 Nov 01; 136(20):1726-1729. PubMed ID: 27830907
    [Abstract] [Full Text] [Related]

  • 37. Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.
    Amato MP, Portaccio E.
    CNS Drugs; 2015 Mar 01; 29(3):207-20. PubMed ID: 25773609
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis.
    Neuhaus O, Kieseier BC, Hartung HP.
    J Neurol Sci; 2007 Aug 15; 259(1-2):27-37. PubMed ID: 17391705
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.